The largest study ever to look at why an expensive and commonly used group of drugs fails patients with Crohn's disease has concluded that standardised drug doses are often too low.
Feb 27, 2019
0
83
Fibromyalgia is something of a mystery. It can't be detected with scans or blood tests, yet it causes lifelong pain for millions of people.
Sep 14, 2018
1
161
Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost. A recent analysis ...
Mar 3, 2017
0
3
Between 3 and 5 percent of the population suffers from a form of inflammatory rheumatism. It affects approximately 250,000 to 400,000 people in Austria. Rheumatoid arthritis is one of the most common and also the most dangerous ...
Mar 2, 2017
0
22
Tumour necrosis factor (TNF), a messenger substance in the immune system, plays an important role in triggering chronic inflammatory diseases. For this reason, TNF inhibitors are a standard form of treatment for patients ...
Jul 11, 2016
0
1
Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis, according to research presented today at Frontiers in CardioVascular Biology (FCVB) 2016 by Professor Aida Babaeva, head of the Department of ...
Jul 9, 2016
0
5
Research from life scientists at The University of Manchester has shone new light on the way cells tune in to different inflammatory signals to understand what is happening in the body.
Jul 6, 2016
0
119
The results of a UK study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that tumour necrosis factor inhibitor (anti-TNF) treatment is effective at improving both muscle and ...
Jun 10, 2016
0
2
Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear. But mounting evidence implicates the immune ...
May 24, 2016
0
33
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour ...
Jun 13, 2015
1
6
